Therefore, practitioners have had to prescribe many of these ophthalmic preparations empirically. In 1997, the U.S. Congress enacted a new law providing marketing incentives for pediatric drug ...

chloramphenicol ophthalmic ointment and solution, erythromycin ophthalmic ointment, Quixin® ophthalmic solution (levofloxacin), Chibroxin® ophthalmic solution (norfloxacin) and Ilotycin ...

Re­gen­eron is go­ing af­ter San­doz in a New Jer­sey fed­er­al court over San­doz’s re­cent­ly-ap­proved drug En­zee­vu, a biosim­i­lar to Re­gen­eron’s block­buster eye tr ...

Ocugen, Inc. OCGN announced that Health Canada has provided it a No Objection Letter to initiate the phase III liMeliGhT study evaluating its modifier gene therapy product candidate, OCU400, for ...